Equities

1nkemia IUCT Group SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert

1nkemia IUCT Group SA

Actions
  • Price (EUR)0.31
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta0.0000
Data delayed at least 15 minutes, as of Mar 04 2026.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

1nkemia IUCT Group SA is a Spain-based company primarily specialized in the biotechnological sector. The Company provides products and services for chemical, pharmaceutical, biopharmaceutical, life science and related industry. The Company’s activity is related to the generation, promotion, development and sale of products and services via a a pipeline of products, processes, services and technological platforms supplied by the Group's subsidiaries.

  • Revenue in EUR (TTM)5.46m
  • Net income in EUR-24.32m
  • Incorporated2010
  • Employees45.00
  • Location
    1nkemia IUCT Group SAC/ Alvarez de Castro, 63MOLLET DEL VALLES 08100SpainESP
  • Phone+34 935793432
  • Fax+34 935705745
  • Websitehttps://www.inkemia.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
EvoNext Holdings Ltd0.00-938.63k7.35m0.00--1.07-----0.1188-0.11880.000.86460.00-------11.30-38.79-12.77-43.27---38.22---515.82----0.00---100.00--100.99------
Spago Nanomedical AB (publ)40.95k-2.49m7.41m7.00--2.57--180.91-0.0513-0.05130.00080.04650.0115--4.3962,428.57-69.64-30.44-81.41-32.48-----6,076.43-3,410.33---------77.135.0218.32------
IDL Diagnostics AB (publ)4.98m-2.98m7.56m22.00--0.5442--1.52-0.1379-0.13790.23060.64320.34175.695.03---20.43-25.11-22.66-27.0033.5314.91-59.78-110.472.83--0.082---7.54263.2371.38------
Medicofarma Biotech SA65.96k-715.98k7.60m24.00--6.81--115.21-0.0450-0.04500.00410.070.019966.640.746911,727.08-21.55-14.96-31.48-18.5938.8036.02-1,085.51-64.020.821-11.710.00--63.14-17.3933.11------
Opsy Holding AB627.01k-736.08k8.33m7.00--57.60--13.28-8.55-8.550.7050.12150.8126--9.41955,857.10-95.38-129.63-199.92-161.05144.70---117.38-2,431.63---69.760.435------62.94--43.17--
1nkemia IUCT Group SA5.46m-24.32m8.36m45.00------1.53-0.9012-0.90120.2024-0.28970.2021.312.14---90.11-56.59-171.35-7,853.1691.46109.22-445.97-319.630.2643.181.74---71.31-60.97-346.13---78.18--
IXICO PLC7.51m-1.90m8.36m79.00--0.6198--1.11-0.0186-0.01860.0730.12670.5222--3.1882,708.86-13.19-3.47-15.43-4.0348.7155.52-25.27-6.21----0.015--13.32-7.2717.49---5.30--
Futura Medical PLC9.11m-7.24m8.37m12.00--1.25--0.9186-0.0207-0.02070.02610.011.06137.368.58---84.19-45.00-112.42-71.7970.67---79.41-108.252.21--0.00--349.09237.55119.85--121.02--
Biosergen AB0.00-3.82m8.45m1.00---------17.68-17.680.00---------------------------------------112.64------
Sds Optic SA708.79k-707.61k8.80m41.00--31.15--12.42-0.5058-0.50580.50200.19130.17920.3612.25---17.98-31.44-18.90-34.7991.1757.78-100.39-122.692.42-2.51-----31.78303.1440.23------
Coegin Pharma AB7.40k-1.92m9.05m3.00--20.35--1,221.83-0.824-0.8240.00320.19070.0039--2.16---101.52-113.82-136.64-160.62-974.68---25,945.57-170,432.90---681.70--------13.81------
Biovica International AB924.34k-7.17m9.05m24.00--0.8205--9.79-0.6375-0.63750.06840.42410.079912.714.46365,333.30-61.92-58.22-70.41-66.49-171.53-462.09-775.22-1,804.168.11--0.0239--18.2338.8329.80---47.26--
Plant Advanced Technologies PAT SA941.74k318.01k9.29m16.0029.540.97810.519.860.27760.27760.83778.38------58,858.75---1.51---1.96144.97128.3233.77-13.360.3156--0.2867--14.6110.441,081.17------
Alzinova AB19.21k-2.52m9.38m5.00--0.4896--488.54-0.2846-0.28460.00221.230.0015--0.325441,000.00-19.42-12.21-20.69-12.85-5,834.15---13,114.15-21,390.81---1,794.800.0062---88.89---24.71--19.48--
Annexin Pharmaceuticals AB (publ)0.00-3.46m9.46m4.00--4.05-----5.98-5.980.003.530.00----0.00-150.00-137.53-190.93-169.50------------0.00------26.58------
Glycorex Transplantation AB (publ)3.64m-723.43k9.49m20.00--3.0664.312.61-0.0983-0.09830.49520.4380.76851.356.371,942,200.00-15.27-17.65-20.85-21.4582.8485.42-19.87-41.501.35-16.240.1682--10.487.5529.44---37.57--
Data as of Mar 04 2026. Currency figures normalised to 1nkemia IUCT Group SA's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.